DrugPatentWatch Database Preview
Msn - Profile
» See Plans and Pricing
Drugs and US Patents for Msn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msn | FEBUXOSTAT | febuxostat | TABLET;ORAL | 210461-001 | Dec 30, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Msn | CAPECITABINE | capecitabine | TABLET;ORAL | 209365-002 | Jul 2, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Msn | SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 210688-002 | May 20, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Msn | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 209878-002 | Nov 20, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Msn | DECITABINE | decitabine | INJECTABLE;INTRAVENOUS | 212265-001 | Aug 28, 2019 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
